Parallax Volatility Advisers
PDLI

Parallax Volatility Advisers’s PDL BioPharma, Inc. PDLI Stock Holding History

Parallax Volatility Advisers’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-11,618
Closed -$31K – 4508
2018
Q3 		$31K Sell
11,618
-8,295
-42% -$20.4K ﹤0.01% 2021
2018
Q2 		$47K Buy
19,913
+2,268
+13% +$6.33K ﹤0.01% 1653
2018
Q1 		$52K Sell
17,645
-6,799
-28% -$18.6K ﹤0.01% 1560
2017
Q4 		$67K Buy
+24,444
New +$75.1K ﹤0.01% 3051

Other funds holding PDLI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Parallax Volatility Advisers's PDLI Position: Q4 2018 in Review

Parallax Volatility Advisers sold out of PDL BioPharma, Inc. (PDLI) in Q4 2018, closing a stake of 11,618 shares — an estimated $31K sold.

Parallax Volatility Advisers first reported a position in PDLI in Q4 2017 and held it in 4 quarters. The position peaked at $67K in Q4 2017. 154 funds tracked by Wall St. Rank hold PDLI as of Q4 2018.

  • Parallax Volatility Advisers reported no remaining PDL BioPharma, Inc. position as of Q4 2018 after selling out during the quarter.
  • Parallax Volatility Advisers sold 11,618 PDL BioPharma, Inc. shares in Q4 2018, an estimated $31K.
  • Parallax Volatility Advisers first reported a position in PDL BioPharma, Inc. in Q4 2017 and held it in 4 quarters.
  • Parallax Volatility Advisers's PDL BioPharma, Inc. position peaked at $67K in Q4 2017.
  • 154 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2018.

Based on Parallax Volatility Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.